Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Healthcare...

    Fortis Healthcare extends deadline for submission of binding bids to June 28

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-06-13T10:36:38+05:30  |  Updated On 13 Jun 2018 10:36 AM IST
    Fortis Healthcare extends deadline for submission of binding bids to June 28

    New Delhi: Cash-strapped Fortis Healthcare, which is in the process of finding a buyer, has extended the deadline for submission of binding bids to June 28.


    Earlier this month, Fortis Healthcare had shortlisted four entities -- the Munjal-Burman combine, Manipal-TPG consortium, Malaysia's IHH Healthcare Berhad and Radiant Life Care to bid for the sale of its business.


    Last month, Fortis Healthcare had initiated a fresh time-bound bidding process for its sale after terminating the offer made by the Munjal-Burman combine.


    The earlier deadline for submitting fresh binding bids was June 14.


    "The date for submission of the binding bids...stands revised to Thursday, June 28, 2018," Fortis Healthcare said in a regulatory filing.


    As per the criteria set by the company, the buyers have to make a minimum investment of Rs 1,500 crore into Fortis Healthcare by way of preferential allotment apart from having a plan for funding the acquisition of RHT Health Trust (RHT) and a plan for providing exit to private equity investors of diagnostic arm SRL.


    Among others, the bids should be unconditional as well as mention the source of funds for the transaction and elaborate on the plans for retention of current management and employees.


    Yesterday, Fortis Healthcare had again deferred approval of quarterly and annual financial results for the period ended March 31, 2018, saying more time is needed to consider the aspects of outcome of an internal investigation into alleged financial irregularities.


    The date for the approval of the said accounts will be June 25, 2018, it added.


    On May 30, the company had postponed its board meeting scheduled to consider financial results for the fourth quarter and financial year ended March 31, 2018, to June 11.


    It had cited deliberations on the conclusions of the internal investigation on the alleged financial irregularities in the company as reason for the deferment.

    bidding processBinding bidsdeadlineextendsFortisFortis dealFortis HealthcareIHH Healthcare BerhadManipal/TPG consortiumMunjal-BurmanRadiant Life CareRHTRHT Health Trustsubmission
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok